Specify Company / Ticker to Get the Summary
Dividend History GERN
Dividend Analytics GERN
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Geron Corporation
GERNGeron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California. Address: 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404
Analytics
WallStreet Target Price
3.69 USDP/E Ratio
–Dividend Yield
–Financials GERN
Results | 2019 | Dynamics |